Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting

Abstract Background Lupus nephritis (LN) is a major cause of morbidity in childhood-onset systemic lupus erythematosus (cSLE). Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are recommended first-line induction therapies, yet comparative pediatric real-world data, particularly from Asian pop...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Adrienne Katrin M. Guiang-Valerio, Ma. Theresa M. Collante, Christine B. Bernal
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-02-01
Schriftenreihe:	BMC Rheumatology
Schlagworte:	Childhood-onset lupus nephritis Cyclophosphamide Mycophenolate mofetil Systemic lupus erythematosus
Online-Zugang:	https://doi.org/10.1186/s41927-026-00630-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!